/Insulet%20Corporation%20phone%20and%20website-by%20T_Schneider%20via%20Shutterstock.jpg)
With a market cap of $22.8 billion, Insulet Corporation (PODD) is a prominent medical device company specializing in innovative insulin delivery solutions, best known for its flagship Omnipod® Insulin Management System. Headquartered in Acton, Massachusetts, Insulet has carved out a strong niche in the global diabetes care market by offering a tubeless, wearable insulin pump designed to simplify diabetes management and improve quality of life for patients.
Shares of PODD have significantly outpaced the broader market over the past 52 weeks. PODD stock has soared 77.8% over this period, while the broader S&P 500 Index ($SPX) has gained 14.3%. Moreover, shares of PODD are up 26% on a YTD basis, compared to SPX’s 9.5% rise.